Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹451.90
11.75 (2.67%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹17.29K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
85.7
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹266.7+69.4%
52W High₹1,121.15-59.7%
Current Price
₹451.90
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹361.52
Upper Circuit₹542.28
Reference Price
₹451.90
Investment Checklist
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹479.4
Descending Channel on 1W — target ₹438.34
Volume divergence: Bearish (price up, volume down)
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
EMA(20) Crossover: Price crossed above EMA(20): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
51%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
441.84
EMA50
428.85
EMA200
544.97
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows6
Lower Highs5
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹486.30
₹505.00
₹518.12
₹545.00
₹856.45
Support (Below)
₹448.00
₹418.55
₹403.96
₹391.05
₹355.05
Volume Analysis
TrendDECREASING
Change-83.90%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹447.38
3% Risk₹438.34
5% Risk₹429.30
7% Risk (Custom)
₹420.27Technical Levels
1x ATR (Volatility)₹432.56
2x ATR (Swing)₹413.22
3x ATR (Trend)₹393.88
Immediate Support₹448.00
Moving Averages
EMA 9 (Short-term)₹445.23
EMA 20 (Medium-term)₹441.84
EMA 50 (Trend)₹428.85
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹376.7 Cr | ₹549.3 Cr | ₹555.6 Cr | ₹544.6 Cr |
| Net Profit | ₹42 Cr | ₹48.8 Cr | ₹74.1 Cr | ₹36.7 Cr |
| EPS | — | ₹1.28 | ₹1.94 | ₹0.96 |
| Operating Profit | ₹83.3 Cr | ₹118.1 Cr | ₹136.6 Cr | ₹96.7 Cr |
ROE
15.79%
ROCE
17.99%
Debt/Equity
0.16
Current Ratio
2.43
OPM
17.75%
NPM
6.74%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Cohance Lifesciences Limited | ₹451.90 | +2.67% | 85.7 | ₹17.29K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 06 Aug 2024 | Annual General Meeting | AGM |
| 12 Dec 2023 | Annual General Meeting | AGM |
| 09 Sept 2022 | Interim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share | SPECIAL_DIVIDEND |
| 11 Aug 2022 | Annual General Meeting | AGM |
| 13 May 2022 | Interim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share | SPECIAL_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for COHANCE
View All
negative
ET Markets - Stocks 1d ago
10 Nifty 500 stocks plunge over 50% from 52-week highs. Do you own any?
Nifty 500 stocks experienced sharp declines, far exceeding index movements. Several companies saw their values drop by over fifty percent from recent highs. Reliance Power and Cohance Lifesciences are among the biggest losers in this market correction.
AONETMMQ50AONETOTALBANKIETFCOHANCEGROWWLOVOLGROWWMOM50GVPILHEALTHCAREMOCAPITALMOMENTUM50MONIFTY500MULTICAPPVTBANIETFRELIANCERELINFRARPOWERVALUECapital GoodsFinancial Services
NEWS
positive
Business Standard - Markets 17d ago
Volumes spurt at Cohance Lifesciences Ltd counter
Cohance Lifesciences Ltd registered volume of 234.51 lakh shares by 14:14 IST on NSE, a 41.19 fold spurt over two-week average daily volume of 5.69 lakh shares
COHANCEHealthcare
NEWS
neutral
Business Standard - Markets 17d ago
Cohance Lifesciences Ltd leads gainers in 'A' group
Piramal Pharma Ltd, Jain Irrigation Systems Ltd, Aarti Pharmalabs Ltd and BASF India Ltd are among the other gainers in the BSE's 'A' group today, 23 June 2026.
AARTIINDAARTIPHARMBASFBSECOHANCEJISLDVREQSJISLJALEQSPOLYSILPPLPHARMARSYSTEMSCapital GoodsChemicals